Neuralink, a brain-chip startup founded by tech billionaire Elon Musk, announced on Tuesday that it has been given the go-ahead to start recruiting for the first human trial of its brain implant for paralysis patients.
The company stated that those with paralysis brought on by amyotrophic lateral sclerosis or cervical spinal cord damage may be eligible for the study.
According to Neuralink, the study’s primary objective is to make it possible for people to operate a computer cursor or keyboard just with their thoughts.
To achieve this, a brain-computer interface (BCI) implant will be surgically implanted in a part of the brain that governs the intention to move.
The first human patient will soon receive a Neuralink device. This ultimately has the potential to restore full body movement.
In the long term, Neuralink hopes to play a role in AI risk civilizational risk reduction by improving human to AI (and human to human) bandwidth by… https://t.co/DzqoYI27Ng
— Elon Musk (@elonmusk) September 20, 2023
Musk, who has high hopes for Neuralink, claims that the company would enable quick surgical insertions of its chip devices to cure illnesses like obesity, autism, depression, and schizophrenia.
